Company intelligence / Profile preview

Costello Medical

Cambridge, United Kingdomcostellomedical.com ↗

Ownership: Private
Employees: ~450
Development stage: Other

Overview

Costello Medical provides scientific support for the analysis, interpretation and communication of clinical and health economic data. It offers expertise in evidence development, statistics, health economics/outcomes research (HEOR), market access strategy for pharmaceuticals and MedTech products globally. The company has received B Corp certification for its social/environmental standards and was awarded the King’s Award for Enterprise in International Trade in 2025. It does not conduct clinical trials or have its own drug pipeline.

Modalities: Small moleculesBiologicsMedical devicesDiagnosticsDigital health technologies
Industry: Consulting

Partnerships

Works with leading pharmaceutical companies and device manufacturers globally; specific partners are confidential/not publicly listed.

Beyond the preview

Go deeper on Costello Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Costello Medical.

Explore the full profile